- In June 2024, Epigenica, a pioneering start-up in epigenomic research, launched its EpiFinder Platform, introducing a patented high-throughput, multiplexing, quantitative ChIP-seq (hmqChIP-seq) technology. Alongside this, the company unveiled EpiFinder Genome, a solution designed for comprehensive genome-wide epigenomic profiling
- In February 2022, Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, entered a partnership with Dovetail Genomics to demonstrate the value and performance of Dovetail’s proximity ligation-based-based next-generation sequencing (NGS) library prep solutions on Element’s AVITI System
